CHRISTY SHAFFER

Profile

First Name

: CHRISTY

Middle Name

:

Last Name

: SHAFFER

Related Companies
Titles
Company Name
Related People
DIRECTOR
CLINIPACE INC
BRIAN CARNEY, JOHN CRUMPLER, MELISSA DANIELS, DAVID FITZGERALD, JULIA GREGORY, KEN LEE, STEVEN LIST, JEREMY MARIO, JASON MONTELEONE, CHRISTOPHER K PORTER, CHRISTOPHER K. PORTER, GENA REED, CHRIS SEMPLE, STEVE SKOLSKY, MARK UBERT, JESSE WATSON, RICK WIDIN, JEFF WILLIAMS, JEFF L WILLIAMS, JEFF L. WILLIAMS
DIRECTOR
EVOAPP, INC.
RYAN P.M. ALLIS, ROBERT BICKSLER, LEONARD BUCK, JOSEPH DAVY, JOSEPH PATRICK DAVY, MARCO FREGENAL, MARCO A. FREGENAL, KIP FREY, J. THOMAS MCMURRAY, ALEXEY MELNICHENKO, ALEXEY A. MELNICHENKO, MICHAEL J. PRESTON
DIRECTOR, PROMOTER
CLEARSIDE BIOMEDICAL, INC.
GERALD D. CAGLE, JERRY CAGLE, GERALD D. CAGLE, PH.D., RICHARD CROARKIN, CHARLES DEIGNAN, CHARLES A. DEIGNAN, CHARLIE DEIGNAN, JEFFREY L. EDWARDS, WILLIAM HUMPHRIES, WILLIAM D. HUMPHRIES, GEORGE LASEZKAY, GLENN NORONHA, MARK PRAUSNITZ, CHRISTY L. SHAFFER, CHRISTY L. SHAFFER, PH.D., CLAY THORP, CLAY B. THORP, DANIEL WHITE, DANIEL H. WHITE, DEREK YOON, EVGENY ZAYTSEV
DIRECTOR
G-ZERO THERAPEUTICS, INC.
CLAUDIA A. BLACK, FREDERIC N. ESHELMAN, MICHAEL GUTCH, PETER KOLCHINSKY, RON LAUFER, THOMAS K LAUNDON, GREGORY MOSSINGHOFF, GLENN MUIR, SETH RUDNICK, SETH A. RUDNICK, NORMAN SHARPLESS, JAY STAUN, JAY STRUM, TIMOTHY SULLIVAN, CLAY THORP, MARK A. VELLECA, CAROL WEBB, KWOK-KIN WONG
DIRECTOR
G1 THERAPEUTICS, INC.
CLAUDIA A. BLACK, FREDERIC N. ESHELMAN, MICHAEL GUTCH, PETER KOLCHINSKY, RON LAUFER, THOMAS K LAUNDON, GREGORY MOSSINGHOFF, GLENN MUIR, SETH RUDNICK, SETH A. RUDNICK, NORMAN SHARPLESS, JAY STAUN, JAY STRUM, TIMOTHY SULLIVAN, CLAY THORP, MARK A. VELLECA, CAROL WEBB, KWOK-KIN WONG
DIRECTOR
KINODYN, INC.
MICHAEL DIAL, LEE M. GRAVES, GARY L. JOHNSON, NATHAN P. LETTS, HOLDEN THORPE
DIRECTOR
SPYRYX BIOSCIENCES, INC.
TIMM CROWDER, BRIAN DANIELS, ROGER JEFFS, ANDREW JORDAN, DONALD ROSE, TIM SHANNON, ROBERT TARRAN, JOHN TAYLOR
EXECUTIVE OFFICER
HATTERAS VENTURE PARTNERS V, LP
JOHN C. CRUMPLER, - HATTERAS VENTURE ADVISORS V, LLC, ROBERT A. INGRAM, DOUGLAS REED, CLAY B. THORP
EXECUTIVE OFFICER, DIRECTOR
GRAYBUG, INC.
ERIC BJERKHOLT, GERALD CAGLE, GERALD CAGLE, PH.D., JEFFREY CLELAND, JEFFREY L. CLELAND, EMMETT CUNNINGHAM, EMMETT CUNNINGHAM, M.D., PH.D., MICHAEL J. DUNN, DANIEL GEFFKEN, FREDERIC GUERARD, JUSTIN HANES, SUDARSHAN HEBBAR, HANSOO MICHAEL KEYOUNG, CHAU KHOUNG, CHAU KHUONG, A. RACHEL LEHENY, FRED MIDDLETON, MICHAEL O-ROURKE, ERIC W. ROBERTS, CHRISTY SHAFFER, PH.D., ALLAN SHAW, KENNETH A. STAUDERMAN, PAMELA WAPNICK, CAMERON WHEELER, CAMERON WHEELER, PH.D., ROBERT N. WILSON, CHRISTY WYSKIEL
DIRECTOR
TREFOIL THERAPEUTICS, INC.
RALPH BRADSHAW, DAVID EVELETH, JOHN FUCCI, BEN MCGRAW, JONATHAN MOW, SCHALON NEWTON, STELLA ROBERTSON, KSENIYA SIMPSON, DEREK YOON
EXECUTIVE OFFICER, DIRECTOR
GRAYBUG VISION, INC.
ERIC BJERKHOLT, GERALD CAGLE, GERALD CAGLE, PH.D., JEFFREY CLELAND, JEFFREY L. CLELAND, EMMETT CUNNINGHAM, EMMETT CUNNINGHAM, M.D., PH.D., MICHAEL J. DUNN, DANIEL GEFFKEN, FREDERIC GUERARD, JUSTIN HANES, SUDARSHAN HEBBAR, HANSOO MICHAEL KEYOUNG, CHAU KHOUNG, CHAU KHUONG, A. RACHEL LEHENY, FRED MIDDLETON, MICHAEL O-ROURKE, ERIC W. ROBERTS, CHRISTY SHAFFER, PH.D., ALLAN SHAW, KENNETH A. STAUDERMAN, PAMELA WAPNICK, CAMERON WHEELER, CAMERON WHEELER, PH.D., ROBERT N. WILSON, CHRISTY WYSKIEL
DIRECTOR
ARTIZAN BIOSCIENCES, INC.
HEATHER MADSEN, BRIDGET ANN MARTELL, DONNIE MCGRATH, ST. JOHN DONNIE MCGRATH, MARIAN NAKADA, JAMES H. ROSEN, MONCEF SLAOUI, E. JONATHAN SODERSTROM, JONATHAN SODERSTROM, CLAY THORP, HOLDEN THORP, WILLIAM WIESLER
DIRECTOR
PERFUSE THERAPEUTICS, INC.
DAN BECKER, JERRY CAGLE, SEVGI GURKAN, CHAU KHUONG, HONGBO LU
EXECUTIVE OFFICER
HATTERAS VENTURE PARTNERS VI, LP
JOHN C. CRUMPLER, MICHAEL DIAL, - HATTERAS VENTURE ADVISORS VI, LLC, ROBERT A. INGRAM, DOUGLAS REED, JEFFREY TERRELL, CLAY B. THORP
DIRECTOR
AER THERAPEUTICS, INC.
JOHN FAHY, RISHI GUPTA, THOMAS MATHERS, JAMES SHAFFER, TIM SHANNON
EXECUTIVE OFFICER
HATTERAS VENTURE PARTNERS VII, LP
JOHN C. CRUMPLER, MICHAEL DIAL, - HATTERAS VENTURE ADVISORS VII, LLC, ROBERT A. INGRAM, DOUGLAS REED, JEFFREY TERRELL, CLAY B. THORP
EXECUTIVE OFFICER
HATTERAS OPPORTUNITY FUND I, LP
JOHN C. CRUMPLER, MICHAEL DIAL, - HATTERAS VENTURE ADVISORS VII, LLC, ROBERT A. INGRAM, DOUGLAS REED, JEFFREY TERRELL, CLAY B. THORP
EXECUTIVE OFFICER
HATTERAS CREATE SF SPV, LLC
JOHN C. CRUMPLER, MICHAEL DIAL, - HATTERAS VENTURE ADVISORS VI, LLC, DOUGLAS REED, CLAY B. THORP
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-04-13
D
Link
INVESTING 
 
DECLINE TO DISCLOSE 
Equity 
2026-03-02 
2025-05-07
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-04-23 
2025-02-07
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-01-24 
2024-03-07
D/A
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
Equity 
2022-02-02 
2023-09-08
D/A
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
Equity 
2021-12-22 
2023-02-03
D
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
Equity 
2022-02-02 
2023-02-02
D
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
Equity 
2021-12-22 
2022-12-22
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-12-09 
2022-06-15
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-12-21 
2022-03-22
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-03-08 
2020-12-23
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-12-21 
2020-10-15
D/A
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
Equity 
2019-04-01 
2020-07-29
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-07-15 
2020-03-04
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2020-02-28 
2019-08-05
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-07-03 
2019-07-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-07-03 
2019-04-15
D
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
Equity 
2019-04-01 
2019-04-04
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-03-21 
2019-03-08
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-03-04 
2018-10-04
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2018-10-01 
2018-06-13
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-04-29 
2017-07-18
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-04-29 
2017-07-12
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2017-06-27 
2016-12-08
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-12-01 
2016-07-01
D/A
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2016-04-27 
2016-05-13
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-04-29 
2016-05-11
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2016-04-27 
2015-12-21
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2015-12-11 
2015-12-08
D
Link
OTHER TECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2015-11-23 
2015-12-07
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-11-23 
2015-08-24
D
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
Equity 
2015-08-07 
2015-05-08
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-04-24 
2015-02-12
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-02-04 
2014-09-15
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2014-08-29 
2014-06-23
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-10-08 
2014-06-19
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2014-06-13 
2014-05-12
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2014-04-28 
2013-10-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-10-08 
2013-08-23
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2013-04-03 
2013-04-18
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2013-04-03 
2013-02-12
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2013-01-31 
2012-04-20
D/A
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-11-01 
2012-02-16
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-01-03 
2012-01-09
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-01-03 
2011-11-16
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-11-01 
2011-05-10
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Debt 
2011-04-11 
2011-05-09
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Debt 
2011-05-05 
2011-02-11
D
Link
OTHER TECHNOLOGY 
 
NO REVENUES 
Equity 
2011-02-02 
2009-11-23
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2009-11-09